The company’s immune-based protein signature MeMed BV distinguishes between bacterial and viral infections, helping physicians determine whether antibiotic treatment is appropriate.
Read more here.
The company’s immune-based protein signature MeMed BV distinguishes between bacterial and viral infections, helping physicians determine whether antibiotic treatment is appropriate.
Read more here.
![[ReWalk in GlobeNewsWire] ReWalk Robotics demonstrates AI autonomous decision making in next generation exoskeleton prototype](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
